Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Recruiting · NCT06375473 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Irinotecan liposome II combination therapy regimen
What this trial is about
This study is a multi-center observational study.The start time for data collection is May 1, 2024. Patients' baseline and treatment data will be collected under informed concent. The purpose of this case registry study was to evaluate the safety and efficacy of irinotecan hydrochloride liposome injection II based therapy in Chinese patients with pancreatic cancer in the real world by collecting, understanding, and analyzing the etiology, clinical features, treatment pattern, treatment outcomes, and pharmacoeconomics changes in pancreatic cancer patients receiving this regimen.
Who can take part
Age range
18 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with pancreatic ductal adenocarcinoma diagnosed by pathology or imaging;
- Age ≥18 years old, male or female;
- Patients receiving treatment based on irinotecan hydrochloride liposome injection II;
- The subjects voluntarily joined the study and signed the informed consent.
Exclusion criteria
- Confirmed pregnant or lactating women;
- The researchers determined that other conditions were not suitable for inclusion in the study.
Where it is running
10 locations listed.
- Peking Unicersity First Hospital - Beijing, China
- Henan Provincial People's Hospital - Henan, China
- Ningbo Medical Center Lihuili Hospital - Ningbo, China
- Fudan University Shanghai Cancer Center - Shanghai, China
- Renji，Hospital - Shanghai, China
- Wuhan Union Hospital of China - Wuhan, China
- Anhui Provincial Cancer Hospital - Hefei, Anhui, China
- Peking Union Medical College Hospital - Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Guangxi Medical University - Nanning, Guangxi, China
- The First Affiliated Hospital of Zhengzhou University - Zhengzhou, Henan, China